This article is part of the network’s archive of useful research information. This article is closed to new comments due to inactivity. We welcome new content which can be done by submitting an article for review or take part in discussions in an open topic or submit a blog post to take your discussions online.
Emerging Infectious Diseases, November 2017
Carlo Fischer, Maria C. Torres, Pranav Patel, Andres Moreira-Soto, Ernest A. Gould, Rémi N. Charrel, Xavier de Lamballerie, Rita Maria Ribeiro Nogueira, Patricia C Sequeira, Cintia D S Rodrigues, Beate M. Kümmerer, Christian Drosten, Olfert Landt, Ana Maria Bispo de Filippis, and Jan Felix Drexler
Summary
The current yellow fever outbreak in Brazil prompted widespread yellow fever virus (YFV) vaccination campaigns, imposing a responsibility to distinguish between vaccine- and wild-type YFV-associated disease. The authors of this study developed novel multiplex real-time reverse transcription PCRs that differentiate between vaccine and American wild-type YFV. Then, they validated these highly specific and sensitive assays in an outbreak setting.
https://wwwnc.cdc.gov/eid/article/23/11/17-1131_article